Cabaletta Bio CABA Cash Flow Statement (2018-2026)

NASDAQ CABA
$1.52 -0.02 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

Cabaletta Bio Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Cabaletta Bio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 31 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.13M-44.87M-41.92M-50.93M
Depreciation and DepletionDep. & Depletion
0.16M0.22M0.23M0.22M0.24M0.36M0.36M0.37M0.37M0.36M0.34M0.39M0.43M0.42M0.47M0.49M0.47M0.35M0.35M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.16M0.22M0.23M0.22M0.24M0.36M0.36M0.37M0.37M0.36M0.34M0.39M0.43M0.42M0.47M0.49M0.47M0.35M0.35M
Share-based CompensationStock Comp.
1.39M1.51M1.60M1.81M1.78M1.73M1.58M2.48M2.80M3.01M3.05M3.79M5.01M5.25M5.41M5.16M5.71M5.82M4.26M
Other non-cash itemsOther Non-Cash
3.04M0.56M0.56M0.59M0.78M1.62M1.96M2.00M-2.29M1.08M1.08M1.13M1.14M
Change in Working Capital
Change in Account PayablesChange Payables
0.96M-0.22M0.57M1.71M-1.87M-0.89M1.03M1.72M-1.87M1.30M0.52M1.66M-1.34M-2.01M2.70M1.59M0.60M1.07M-1.71M
Change in Accured ExpensesChange Accured Exp.
0.53M1.09M1.73M-3.02M1.01M0.43M0.40M-1.68M0.94M0.66M3.06M-3.48M1.56M6.45M-0.57M-3.54M5.61M2.31M3.05M
Change in Other Operating AssetsOther Assets Change
-1.50M-0.61M0.76M0.54M-0.31M0.07M-0.12M-0.38M-0.54M0.84M2.18M1.05M-0.72M-0.30M0.02M0.13M1.09M2.01M2.19M
Change in Other Operating LiabilitiesOther Liabilities Change
-2.91M-0.57M-0.57M-0.57M-0.75M-1.25M-0.97M-1.84M0.77M-1.06M-1.06M-1.06M-1.06M
Other Working Capital ChangesOther WC Changes
1.50M0.61M-0.76M-0.54M0.31M-0.07M-2.79M-0.19M-0.03M-1.41M-2.93M-2.31M-0.25M-1.54M0.75M-1.19M-2.15M-3.07M-3.25M
Cash from OperationsCash from Ops.
-6.58M-8.34M-10.52M-12.81M-11.53M-9.91M-12.13M-12.61M-11.89M-12.60M-16.45M-23.99M-20.79M-20.32M-23.12M-30.80M-30.43M-34.51M-35.34M
Investing Activities
Capital ExpendituresCapex
0.39M0.53M0.15M0.15M0.90M1.09M0.32M0.38M0.06M0.07M0.19M0.81M0.77M0.25M0.38M0.79M0.16M0.08M0.21M
Change in Property, Plant and EquipmentChange in PP&E
-0.39M-0.53M-0.15M-0.15M-0.90M-1.09M-0.32M-0.38M-0.06M-0.07M-0.19M-0.81M-0.77M-0.25M-0.38M-0.79M-0.16M-0.08M-0.21M
Purchase of InvestmentsInvestments Purchased
49.76M48.09M36.18M50.00M
Sale and Maturity of InvestmentsInvestments Sold
1.42M2.30M1.00M25.00M25.00M37.50M24.50M12.50M12.50M50.00M
Cash from Investing ActivitiesCash from Investing
1.03M1.77M0.85M-49.91M-0.90M23.91M-0.32M24.62M-48.14M-0.07M1.14M-0.81M23.73M12.25M12.12M-0.79M-49.20M-50.08M49.80M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.90M0.55M3.00M0.80M1.91M
Non-Current Debt
-0.90M-0.55M-3.00M-0.80M-1.91M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.90M-0.55M-3.00M-0.80M-1.91M
Change in Capital Stock
Common Stock IssuedStock Issued
7.77M25.34M13.63M0.05M0.04M32.89M0.23M94.26M0.10M93.05M6.86M-5.37M0.07M0.14M10.00M83.77M0.09M
Net Shares Issued and RepurchasedNet Shares Issued
7.77M25.34M13.63M0.05M0.04M32.89M0.23M94.26M0.10M93.05M6.86M-5.37M0.07M0.14M10.00M83.77M0.09M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
7.77M25.34M13.63M0.05M0.04M32.89M0.23M94.26M0.10M93.05M6.86M-5.37M0.07M0.14M10.00M83.77M0.09M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
7.77M25.34M13.63M0.05M0.04M32.89M0.23M94.26M0.10M93.05M6.86M0.38M0.07M4.37M-0.55M93.37M-0.81M8.33M
Additional items
Exchange Rate EffectFX Effect
-0.02M0.01M0.03M-0.01M-0.01M
Change in Cash
2.22M18.77M3.96M-62.67M-12.38M13.99M20.44M12.24M34.23M-12.57M77.74M-17.95M3.32M-8.01M-6.65M-32.13M13.78M-85.41M22.78M
Ending Cash Balance
99.50M118.26M122.22M59.55M47.17M61.16M81.61M93.85M128.07M115.50M193.24M175.29M178.61M170.61M163.96M131.83M145.61M60.21M82.98M225.10M
Free Cash FlowFCF
-6.97M-8.87M-10.67M-12.96M-12.42M-11.01M-12.45M-12.99M-11.95M-12.67M-16.63M-24.80M-21.56M-20.58M-23.50M-31.59M-30.59M-34.59M-35.55M
Net Cash FlowNCF
2.22M18.77M3.96M-62.67M-12.38M13.99M20.44M12.24M34.23M-12.57M77.74M-17.95M3.32M-8.01M-6.63M-32.14M13.75M-85.40M22.78M
Interest Paid
0.75M0.21M0.56M0.68M0.26M

Cabaletta Bio Cash Flow Statement API

Pull Cabaletta Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CABA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY